The world has realised that the next generation medical products will need Asian inputs to become successful. So, they are flocking to set up their research facilities, do a large part of their drug discovery work and conduct clinical trials in a big way to speed up the drug development process.
To appreciate the Asian companies for their commendable performance and achievements during Calendar Year (CY) 2021, and noting that Asia is the new hub for potential growth and innovation, BioSpectrum Asia is setting the tone for an exciting opportunity in the form of BioSpectrum Asia Excellence Awards 2022.
These awards are an extension to observe and highlight the winners in the long battle to tackle the world's emerging health problems and find solutions. Through these awards, BioSpectrum Asia is playing the role of picking tomorrow's winners, nudging today's entrepreneurs to achieve greater glory and honouring yesterday's key players who laid the foundation for success.
The nominations are open for Jury Special and Editors' Choice categories.
Deadline for the submission of entries is on 30th August 2022.